Role of lncRNAs in prostate cancer development and progression

References

Arab, K., Park, Y.J., Lindroth, A.M., Schafer, A., Oakes, C., Weichenhan, D., Lukanova, A., Lundin, E., Risch, A., Meister, M., et al. (2014). Long noncoding RNA TARID directs demethylation and activation of the tumor suppressor TCF21 via GADD45A. Mol. Cell. 55, 604–614.10.1016/j.molcel.2014.06.031Search in Google Scholar PubMed

Auprich, M., Chun, F.K., Ward, J.F., Pummer, K., Babaian, R., Augustin, H., Luger, F., Gutschi, S., Budaus, L., Fisch, M., et al. (2011). Critical assessment of preoperative urinary prostate cancer antigen 3 on the accuracy of prostate cancer staging. Eur. Urol. 59, 96–105.10.1016/j.eururo.2010.10.024Search in Google Scholar PubMed

Beckedorff, F.C., Ayupe, A.C., Crocci-Souza, R., Amaral, M.S., Nakaya, H.I., Soltys, D.T., Menck, C.F., Reis, E.M., and Verjovski-Almeida, S. (2013). The intronic long noncoding RNA ANRASSF1 recruits PRC2 to the RASSF1A promoter, reducing the expression of RASSF1A and increasing cell proliferation. PLoS Genet. 9, e1003705.10.1371/journal.pgen.1003705Search in Google Scholar PubMed PubMed Central

Berteaux, N., Lottin, S., Adriaenssens, E., Van Coppenolle, F., Leroy, X., Coll, J., Dugimont, T., and Curgy, J.J. (2004). Hormonal regulation of H19 gene expression in prostate epithelial cells. J. Endocrinol. 183, 69–78.10.1677/joe.1.05696Search in Google Scholar PubMed

Borowsky, M., Lee, J.T., Ohsumi, T.K., Sarma, K., and Zhao, J. (2012). Polycomb-associated non-coding rnas. WO 2012087983 A1.Search in Google Scholar

Bray, F., Ren, J.S., Masuyer, E., and Ferlay, J. (2013). Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int. J. Cancer 132, 1133–1145.10.1002/ijc.27711Search in Google Scholar PubMed

Bussemakers, M.J., van Bokhoven, A., Verhaegh, G.W., Smit, F.P., Karthaus, H.F., Schalken, J.A., Debruyne, F.M., Ru, N., and Isaacs, W.B. (1999). DD3: a new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res. 59, 5975–5979.Search in Google Scholar

Chinnaiyan, A., Prensner, J., and Iyer, M. (2012). ncRNA and uses thereof. WO 2012068383 A2.Search in Google Scholar

Chung, S., Nakagawa, H., Uemura, M., Piao, L., Ashikawa, K., Hosono, N., Takata, R., Akamatsu, S., Kawaguchi, T., Morizono, T., et al. (2011). Association of a novel long non-coding RNA in 8q24 with prostate cancer susceptibility. Cancer Sci. 102, 245–252.10.1111/j.1349-7006.2010.01737.xSearch in Google Scholar PubMed

Crea, F., Watahiki, A., Quagliata, L., Xue, H., Pikor, L., Parolia, A., Wang, Y., Lin, D., Lam, W.L., Farrar, W.L., et al. (2014). Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer. Oncotarget 5, 764–774.10.18632/oncotarget.1769Search in Google Scholar PubMed PubMed Central

Cui, Z., Ren, S., Lu, J., Wang, F., Xu, W., Sun, Y., Wei, M., Chen, J., Gao, X., Xu, C., et al. (2013). The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor. Urol. Oncol. 31, 1117–1123.10.1016/j.urolonc.2011.11.030Search in Google Scholar PubMed

Du, Z., Fei, T., Verhaak, R.G., Su, Z., Zhang, Y., Brown, M., Chen, Y., and Liu, X.S. (2013). Integrative genomic analyses reveal clinically relevant long noncoding RNAs in human cancer. Nat. Struct. Mol. Biol. 20, 908–913.10.1038/nsmb.2591Search in Google Scholar PubMed PubMed Central

Ebert, M.S., Neilson, J.R., and Sharp, P.A. (2007). MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat. Methods 4, 721–726.10.1038/nmeth1079Search in Google Scholar PubMed PubMed Central

Esteller, M. (2011). Non-coding RNAs in human disease. Nat. Rev. Genet. 12, 861–874.10.1038/nrg3074Search in Google Scholar PubMed

Ferreira, L.B., Palumbo, A., de Mello, K.D., Sternberg, C., Caetano, M.S., de Oliveira, F.L., Neves, A.F., Nasciutti, L.E., Goulart, L.R., and Gimba, E.R. (2012). PCA3 noncoding RNA is involved in the control of prostate-cancer cell survival and modulates androgen receptor signaling. BMC Cancer 12, 507.10.1186/1471-2407-12-507Search in Google Scholar PubMed PubMed Central

Fu, M., Wang, C., Reutens, A.T., Wang, J., Angeletti, R.H., Siconolfi-Baez, L., Ogryzko, V., Avantaggiati, M.L., and Pestell, R.G. (2000). p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation. J. Biol. Chem. 275, 20853–20860.10.1074/jbc.M000660200Search in Google Scholar PubMed

Fu, V.X., Schwarze, S.R., Kenowski, M.L., Leblanc, S., Svaren, J., and Jarrard, D.F. (2004). A loss of insulin-like growth factor-2 imprinting is modulated by CCCTC-binding factor down-regulation at senescence in human epithelial cells. J. Biol. Chem. 279, 52218–52226.10.1074/jbc.M405015200Search in Google Scholar PubMed

Fu, X., Ravindranath, L., Tran, N., Petrovics, G., and Srivastava, S. (2006). Regulation of apoptosis by a prostate-specific and prostate cancer-associated noncoding gene, PCGEM1. DNA Cell Biol. 25, 135–141.10.1089/dna.2006.25.135Search in Google Scholar PubMed

Fu, V.X., Dobosy, J.R., Desotelle, J.A., Almassi, N., Ewald, J.A., Srinivasan, R., Berres, M., Svaren, J., Weindruch R., and Jarrard, D.F. (2008). Aging and cancer-related loss of insulin-like growth factor 2 imprinting in the mouse and human prostate. Cancer Res. 68, 6797–6802.10.1158/0008-5472.CAN-08-1714Search in Google Scholar PubMed PubMed Central

Grasso, C.S., Wu, Y.M., Robinson, D.R., Cao, X., Dhanasekaran, S.M., Khan, A.P., Quist, M.J., Jing, X., Lonigro, R.J., Brenner, J.C., et al. (2012). The mutational landscape of lethal castration-resistant prostate cancer. Nature 487, 239–243.10.1038/nature11125Search in Google Scholar PubMed PubMed Central

Gregory, R.I. and Shiekhattar, R. (2004). Chromatin modifiers and carcinogenesis. Trends Cell. Biol. 14, 695–702.10.1016/j.tcb.2004.10.002Search in Google Scholar PubMed

Groskopf, J., Aubin, S.M., Deras, I.L., Blase, A., Bodrug, S., Clark, C., Brentano, S., Mathis, J., Pham, J., Meyer, T. et al. (2006). APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer. Clin. Chem. 52, 1089–1095.10.1373/clinchem.2005.063289Search in Google Scholar PubMed

Gutschner, T., Hammerle, M., Eissmann, M., Hsu, J., Kim, Y., Hung, G., Revenko, A., Arun, G., Stentrup, M., Gross, M., et al. (2013). The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res. 73, 1180–1189.10.1158/0008-5472.CAN-12-2850Search in Google Scholar PubMed PubMed Central

Guttman, M., Amit, I., Garber, M., French, C., Lin, M.F., Feldser, D., Huarte, M., Zuk, O., Carey, B.W., Cassady, J.P., et al. (2009). Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 458, 223–227.10.1038/nature07672Search in Google Scholar PubMed PubMed Central

Jelinic, P., Mueller, J.J., Olvera, N., Dao, F., Scott, S.N., Shah, R., Gao, J., Schultz, N., Gonen, M., Soslow, R.A., et al. (2014). Recurrent SMARCA4 mutations in small cell carcinoma of the ovary. Nat. Genet. 46, 424–426.10.1038/ng.2922Search in Google Scholar PubMed PubMed Central

Jeronimo, C., Bastian, P.J., Bjartell, A., Carbone, G.M., Catto, J.W., Clark, S.J., Henrique, R., Nelson, W.G., and Shariat, S.F. (2011). Epigenetics in prostate cancer: biologic and clinical relevance. Eur. Urol. 60, 753–766.10.1016/j.eururo.2011.06.035Search in Google Scholar PubMed

Ji, P., Diederichs, S., Wang, W., Boing, S., Metzger, R., Schneider, P.M., Tidow, N., Brandt, B., Buerger, H., Bulk, E., et al. (2003). MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 22, 8031–8041.10.1038/sj.onc.1206928Search in Google Scholar PubMed

Johnsson, P., Ackley, A., Vidarsdottir, L., Lui, W.O., Corcoran, M., Grander, D., and Morris, K.V. (2013). A pseudogene long-noncoding-RNA network regulates PTEN transcription and translation in human cells. Nat. Struct. Mol. Biol. 20, 440–446.10.1038/nsmb.2516Search in Google Scholar PubMed PubMed Central

Kino, T., Hurt, D.E., Ichijo, T., Nader, N., and Chrousos, G.P. (2010). Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor. Sci. Signal 3, ra8.Search in Google Scholar

Knutson, S.K., Warholic, N.M., Wigle, T.J., Klaus, C.R., Allain, C.J., Raimondi, A., Porter Scott, M., Chesworth, R., Moyer, M.P., Copeland, R.A., et al. (2013). Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2. Proc. Natl. Acad. Sci. USA 110, 7922–7927.10.1073/pnas.1303800110Search in Google Scholar PubMed PubMed Central

Knutson, S.K., Kawano, S., Minoshima, Y., Warholic, N.M., Huang, K.C., Xiao, Y., Kadowaki, T., Uesugi, M., Kuznetsov, G., Kumar, N., et al. (2014). Selective inhibition of EZH2 by EPZ-6438 leads to potent antitumor activity in EZH2-mutant non-Hodgkin lymphoma. Mol. Cancer Ther. 13, 842–854.10.1158/1535-7163.MCT-13-0773Search in Google Scholar PubMed

Kotake, Y., Nakagawa, T., Kitagawa, K., Suzuki, S., Liu, N., Kitagawa, M., and Xiong, Y. (2011). Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene 30, 1956–1962.10.1038/onc.2010.568Search in Google Scholar PubMed PubMed Central

Lee, J.T. (2012). Epigenetic regulation by long noncoding RNAs. Science 338, 1435–1439.10.1126/science.1231776Search in Google Scholar PubMed

Leyten, G.H., Hessels, D., Jannink, S.A., Smit, F.P., de Jong, H., Cornel, E.B., de Reijke, T.M., Vergunst, H., Kil, P., Knipscheer, B.C., et al. (2014). Prospective multicentre evaluation of PCA3 and TMPRSS2-ERG gene fusions as diagnostic and prognostic urinary biomarkers for prostate cancer. Eur. Urol. 65, 5342.10.1016/j.eururo.2012.11.014Search in Google Scholar PubMed

Malik, R., Patel, L., Prensner, J.R., Shi, Y., Iyer, M.K., Subramaniyan, S., Carley, A., Niknafs, Y.S., Sahu, A., Han, S., et al. (2014). The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer. Mol. Cancer Res. 12, 1081–1087.10.1158/1541-7786.MCR-14-0257Search in Google Scholar PubMed PubMed Central

Maruyama, R. and Suzuki, H. (2012). Long noncoding RNA involvement in cancer. BMB Rep. 45, 604–611.10.5483/BMBRep.2012.45.11.227Search in Google Scholar

Mercer, T.R. and Mattick, J.S. (2013). Structure and function of long noncoding RNAs in epigenetic regulation. Nat. Struct. Mol. Biol. 20, 300–307.10.1038/nsmb.2480Search in Google Scholar PubMed

Mills, I.G. (2014). Maintaining and reprogramming genomic androgen receptor activity in prostate cancer. Nat. Rev. Cancer 14, 187–198.10.1038/nrc3678Search in Google Scholar PubMed

Mourtada-Maarabouni, M., Pickard, M.R., Hedge, V.L., Farzaneh, F., and Williams, G.T. (2009). GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene 28, 195–208.10.1038/onc.2008.373Search in Google Scholar PubMed

Orfanelli, U., Jachetti, E., Chiacchiera, F., Grioni, M., Brambilla, P., Briganti, A., Freschi, M., Martinelli-Boneschi, F., Doglioni, C., Montorsi, F., et al. (2014). Antisense transcription at the TRPM2 locus as a novel prognostic marker and therapeutic target in prostate cancer. Oncogene 10.1038/onc.2014.144.Search in Google Scholar

Palakurthy, R.K., Wajapeyee, N., Santra, M.K., Gazin, C., Lin, L., Gobeil, S., and Green, M.R. (2009). Epigenetic silencing of the RASSF1A tumor suppressor gene through HOXB3-mediated induction of DNMT3B expression. Mol. Cell 36, 219–230.10.1016/j.molcel.2009.10.009Search in Google Scholar PubMed PubMed Central

Petrovics, G., Zhang, W., Makarem, M., Street, J.P., Connelly, R., Sun, L., Sesterhenn, I.A., Srikantan, V., Moul, J.W., and Srivastava, S. (2004). Elevated expression of PCGEM1, a prostate-specific gene with cell growth-promoting function, is associated with high-risk prostate cancer patients. Oncogene 23, 605–611.10.1038/sj.onc.1207069Search in Google Scholar PubMed

Phin, S., Moore, M.W., and Cotter, P.D. (2013). Genomic rearrangements of in prostate cancer. Front. Oncol. 3, 240.10.3389/fonc.2013.00240Search in Google Scholar PubMed PubMed Central

Pickard, M.R., Mourtada-Maarabouni, M., and Williams, G.T. (2013). Long non-coding RNA GAS5 regulates apoptosis in prostate cancer cell lines. Biochim. Biophys. Acta 1832, 1613–1623.10.1016/j.bbadis.2013.05.005Search in Google Scholar PubMed

Poliseno, L., Salmena, L., Riccardi, L., Fornari, A., Song, M.S., Hobbs, R.M., Sportoletti, P., Varmeh, S., Egia, A., Fedele G., et al. (2010a). Identification of the miR-106b∼25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation. Sci. Signal. 3, ra29.10.1126/scisignal.2000594Search in Google Scholar PubMed PubMed Central

Poliseno, L., Salmena, L., Zhang, J., Carver, B., Haveman, W.J., and Pandolfi, P.P. (2010b). A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 465, 1033–1038.10.1038/nature09144Search in Google Scholar PubMed PubMed Central

Ponting, C.P., Oliver, P.L., and Reik, W. (2009). Evolution and functions of long noncoding RNAs. Cell 136, 629–641.10.1016/j.cell.2009.02.006Search in Google Scholar PubMed

Prensner, J.R. and Chinnaiyan, A.M. (2011). The emergence of lncRNAs in cancer biology. Cancer Discov. 1, 391–407.10.1158/2159-8290.CD-11-0209Search in Google Scholar PubMed PubMed Central

Prensner, J.R., Iyer, M.K., Balbin, O.A., Dhanasekaran, S.M., Cao, Q., Brenner, J.C., Laxman, B., Asangani, I.A., Grasso, C.S., Kominsky, H.D., et al. (2011). Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nat. Biotechnol. 29, 742–749.10.1038/nbt.1914Search in Google Scholar PubMed PubMed Central

Prensner, J.R., Iyer, M.K., Sahu, A., Asangani, I.A., Cao, Q., Patel, L., Vergara, I.A., Davicioni, E., Erho, N., Ghadessi, M., et al. (2013). The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex. Nat. Genet. 45, 1392–1398.10.1038/ng.2771Search in Google Scholar PubMed PubMed Central

Prensner, J.R., Chen, W., Iyer, M.K., Cao, Q., Ma, T., Han, S., Sahu, A., Malik, R., Wilder-Romans, K., Navone, N., et al. (2014a). PCAT-1, a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancer. Cancer Res. 74, 1651–1660.10.1158/0008-5472.CAN-13-3159Search in Google Scholar PubMed PubMed Central

Prensner, J.R., Sahu, A., Iyer, M.K., Malik, R., Chandler, B., Asangani, I.A., Poliakov, A., Vergara, I.A., Alshalalfa, M., Jenkins, R.B., et al. (2014b). The lncRNAs PCGEM1 and PRNCR1 are not implicated in castration resistant prostate cancer. Oncotarget 30, 1434–1438.10.18632/oncotarget.1846Search in Google Scholar PubMed PubMed Central

Ren, S., Peng, Z., Mao, J.H., Yu, Y., Yin, C., Gao, X., Cui, Z., Zhang, J., Yi, K., Xu, W., et al. (2012). RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicings. Cell Res. 22, 806–821.10.1038/cr.2012.30Search in Google Scholar PubMed PubMed Central

Ren, S., Liu, Y., Xu, W., Sun, Y., Lu, J., Wang, F., Wei, M., Shen, J., Hou, J., Gao, X., et al. (2013a). Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer. J. Urol. 190, 2278–2287.10.1016/j.juro.2013.07.001Search in Google Scholar PubMed

Ren, S., Wang, F., Shen, J., Sun, Y., Xu, W., Lu, J., Wei, M., Xu, C., Wu, C., Zhang, Z., et al. (2013b). Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer. Eur. J. Cancer 49, 2949–2959.10.1016/j.ejca.2013.04.026Search in Google Scholar PubMed

Ribarska, T., Goering, W., Droop, J., Bastian, K.M., Ingenwerth, M., and Schulz, W.A. (2014). Deregulation of an imprinted gene network in prostate cancer. Epigenetics 9, 704–717.10.4161/epi.28006Search in Google Scholar PubMed PubMed Central

Roberts, C.W. and Orkin, S.H. (2004). The SWI/SNF complex – chromatin and cancer. Nat. Rev. Cancer 4, 133–142.10.1038/nrc1273Search in Google Scholar PubMed

Romanuik, T.L., Wang, G., Morozova, O., Delaney, A., Marra, M.A., and Sadar, M.D. (2010). LNCaP Atlas: gene expression associated with in vivo progression to castration-recurrent prostate cancer. BMC Med. Genomics 3, 43.10.1186/1755-8794-3-43Search in Google Scholar PubMed PubMed Central

Sander, J.D. and Joung, J.K. (2014). CRISPR-Cas systems for editing, regulating and targeting genomes. Nat. Biotechnol. 32, 347–355.10.1038/nbt.2842Search in Google Scholar PubMed PubMed Central

Sarma, K., Levasseur, P., Aristarkhov, A., and Lee, J.T. (2010). Locked nucleic acids (LNAs). reveal sequence requirements and kinetics of Xist RNA localization to the X chromosome. Proc. Natl. Acad. Sci. USA 107, 22196–22201.10.1073/pnas.1009785107Search in Google Scholar PubMed PubMed Central

Sherr, C.J. and Roberts, J.M. (1999). CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501–1512.10.1101/gad.13.12.1501Search in Google Scholar PubMed

Simo-Riudalbas, L. and Esteller, M. (2014). Targeting the histone orthography of cancer: drugs for writers, erasers and readers. Br. J. Pharmacol. DOI: 10.1111/bph.12844.10.1111/bph.12844Search in Google Scholar PubMed PubMed Central

Srikantan, V., Zou, Z., Petrovics, G., Xu, L., Augustus, M., Davis, L., Livezey, J.R., Connell, T., Sesterhenn, I.A., Yoshino, K., et al. (2000). PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer. Proc. Natl. Acad. Sci. USA 97, 12216–12221.10.1073/pnas.97.22.12216Search in Google Scholar PubMed PubMed Central

Stevens, M., De Clercq, E., and Balzarini, J. (2006). The regulation of HIV-1 transcription: molecular targets for chemotherapeutic intervention. Med. Res. Rev. 26, 595–625.10.1002/med.20081Search in Google Scholar PubMed PubMed Central

Takayama, K., Tsutsumi, S., Katayama, S., Okayama, T., Horie-Inoue, K., Ikeda, K., Urano, T., Kawazu, C., Hasegawa, A., Ikeo, K., et al. (2011). Integration of cap analysis of gene expression and chromatin immunoprecipitation analysis on array reveals genome-wide androgen receptor signaling in prostate cancer cells. Oncogene 30, 619–630.10.1038/onc.2010.436Search in Google Scholar PubMed

Takayama, K., Horie-Inoue, K., Katayama, S., Suzuki, T., Tsutsumi, S., Ikeda, K., Urano, T., Fujimura, T., Takagi, K., Takahashi, S., et al. (2013). Androgen-responsive long noncoding RNA CTBP1-AS promotes prostate cancer. EMBO J. 32, 1665–1680.10.1038/emboj.2013.99Search in Google Scholar PubMed PubMed Central

Tay, Y., Kats, L., Salmena, L., Weiss, D., Tan, S.M., Ala, U., Karreth, F., Poliseno, L., Provero, P., Di Cunto, F., et al. (2011). Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs. Cell 147, 344–357.10.1016/j.cell.2011.09.029Search in Google Scholar PubMed PubMed Central

Taylor, B.S., Schultz, N., Hieronymus, H., Gopalan, A., Xiao, Y., Carver, B.S., Arora, V.K., Kaushik, P., Cerami, E., Reva, B., et al. (2010). Integrative genomic profiling of human prostate cancer. Cancer Cell 18, 11–22.10.1016/j.ccr.2010.05.026Search in Google Scholar PubMed PubMed Central

Wang, L., Han, S., Jin, G., Zhou, X., Li, M., Ying, X., Wang, L., Wu, H., and Zhu, Q. (2014). Linc00963: a novel, long non-coding RNA involved in the transition of prostate cancer from androgen-dependence to androgen-independence. Int. J. Oncol. 44, 2041–2049.10.3892/ijo.2014.2363Search in Google Scholar PubMed

Weakley, S.M., Wang, H., Yao, Q., and Chen, C. (2011). Expression and function of a large non-coding RNA gene XIST in human cancer. World J. Surg. 35, 1751–1756.10.1007/s00268-010-0951-0Search in Google Scholar PubMed PubMed Central

Weischenfeldt, J., Simon, R., Feuerbach, L., Schlangen, K., Weichenhan, D., Minner, S., Wuttig, D., Warnatz, H.J., Stehr, H., Rausch, T., et al. (2013). Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer. Cancer Cell 23, 159–170.10.1016/j.ccr.2013.01.002Search in Google Scholar PubMed

Wheeler, T.M., Leger, A.J., Pandey, S.K., MacLeod, A.R., Nakamori, M., Cheng, S.H., Wentworth, B.M., Bennett, C.F., and Thornton, C.A. (2012). Targeting nuclear RNA for in vivo correction of myotonic dystrophy. Nature 488, 111–115.10.1038/nature11362Search in Google Scholar PubMed PubMed Central

Yang, L., Lin, C., Jin, C., Yang, J.C., Tanasa, B., Li, W., Merkurjev, D., Ohgi, K.A., Meng, D., Zhang, J., et al. (2013). lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs. Nature 500, 598–602.10.1038/nature12451Search in Google Scholar PubMed PubMed Central

Yap, K.L., Li, S., Munoz-Cabello, A.M., Raguz, S., Zeng, L., Mujtaba, S., Gil, J., Walsh, M.J., and Zhou, M.M. (2010). Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol. Cell 38, 662–674.10.1016/j.molcel.2010.03.021Search in Google Scholar PubMed PubMed Central

Yin, H., Xue, W., Chen, S., Bogorad, R.L., Benedetti, E., Grompe, M., Koteliansky, V., Sharp, P.A., Jacks, T., and Anderson, D.G. (2014). Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype. Nat. Biotechnol. 32, 551–553.10.1038/nbt.2884Search in Google Scholar PubMed PubMed Central

Zhao, J., Ohsumi, T.K., Kung, J.T., Ogawa, Y., Grau, D.J., Sarma, K., Song, J.J., Kingston, R.E., Borowsky, M., and Lee, J.T. (2010). Genome-wide identification of polycomb-associated RNAs by RIP-seq. Mol. Cell 40, 939–953.10.1016/j.molcel.2010.12.011Search in Google Scholar PubMed PubMed Central

Zhou, Y.L., Zhang, X., and Klibanski, A. (2012). MEG3 noncoding RNA: a tumor suppressor. J. Mol. Endocrinol. 48, R45–R53.10.1530/JME-12-0008Search in Google Scholar PubMed PubMed Central